Investor Relations

Investors

Latest News

Tonix Pharmaceuticals to Present at 16th Annual Sachs Biotech in Europe Forum

Read Press Release

Stock Information

Symbol

NASDAQ: TNXP

Price

Loading...

Change

Loading...

MKT Cap

Loading...

Volume

Loading...

52 week Low/High

Loading...

Day Low/High

Loading...

Company Overview

Tonix Pharmaceuticals is a clinical-stage company dedicated to the development of novel pharmaceutical products that it believes will have broad societal impact, as they address medical conditions that are not well served by currently available therapies and represent large potential commercial opportunities. The company is focused in central nervous system (CNS) disorders and is developing therapies for the treatment fibromyalgia and post-traumatic stress disorder. Tonix expects to announce top-line clinical trial results for each of its two development programs in 2016.

IR Contact Information

Investor Relations
TONIX Pharmaceuticals
investor.relations@tonixpharma.com

Transfer Agent
vStock Transfer
77 Spruce Street
Suite 201
Cedarhurst, NY 11516
T: 212-828-8436
www.vstocktransfer.com